Skip to content

Using exercise as a prevention tool for venous leg ulcers

Exploring the feasibility of using an exercise-based, self-managed, lifestyle intervention for venous leg-ulcer prevention in adults with a venous leg-ulcer history (FISCU III)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN16412894
Enrollment
60
Registered
2025-07-07
Start date
2025-08-01
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Venous leg ulcers Circulatory System

Interventions

Exercise lifestyle intervention: 12 months of self-managed exercise programme with embedded behaviour support, followed twice per week. Standard treatment: Compression bandages or hosiery as prescri

Sponsors

Sheffield Health and Social Care NHS Foundation Trust
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Recently (e.g. 3-months) healed from a leg ulcer of primarily venous aetiology (e.g. with ankle brachial pressure index (ABPI) >= 0.8) 2. Able/willing to tolerate lower-limb compression

Exclusion criteria

Exclusion criteria: 1. Do not have the cognitive ability to complete the study assessments (clinician’s judgement) 2. Pregnant 3. Require major surgery within 3 months from eligibility assessment

Design outcomes

Primary

MeasureTime frame
1. Recruitment rates will be measured as rate of invited participants who are eligible and consenting by 12 months since the start of the project. 2. Attrition rates will be established as discontinuation of intervention and loss to follow-up measurement until the end of follow up at 12 months. 3. Suitability of measurement procedures will be evaluated by completion rates and reasons for missing data at the end of follow up at 12 months. 4. The acceptability of FISCU Intervention will be assessed by using session compliance data at the end of follow up at 12 months. 5. Exercise safety will also be assessed by exploring reasons for drop-out from the intervention and the number and type of adverse events that occur in each group at the end of follow up at 12 months.

Secondary

MeasureTime frame
There are no secondary outcome measures

Countries

England, United Kingdom

Contacts

Public ContactMarkos Klonizakis
heartresearchuk@shu.ac.uk+44 1142256000

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026